Towards stem cell replacement therapies for Parkinson's disease.
about
Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vectorStem cell-based approach for the treatment of Parkinson's diseaseMEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat modelClonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy researchOtx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic NeuronsWnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cellsNeural progenitors organize in small-world networks to promote cell proliferationCryopreservation of Human Stem Cells for Clinical Application: A ReviewAmnion-derived stem cells: in quest of clinical applications.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.Progress on stem cell research towards the treatment of Parkinson's disease.Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host MicroenvironmentDopamine receptors in human embryonic stem cell neurodifferentiation.Effects of intravenous human umbilical cord blood CD34+ stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice.Induced pluripotent stem cells and neurodegenerative diseases.Cell replacement therapy for Parkinson's disease: how close are we to the clinic?AAV2-neurturin (CERE-120) for Parkinson's disease.Harnessing neurogenesis for the possible treatment of Parkinson's disease.The (real) neurogenic/gliogenic potential of the postnatal and adult brain parenchyma.Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.Genetic control of midbrain dopaminergic neuron development.Clinical translation of stem cells in neurodegenerative disorders.Development of stem cell-based therapies for Parkinson's disease.Therapeutic potential of neural stem cells: greater in people's perception than in their brains?Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease.In vitro optimization of retinoic acid-induced neuritogenesis and TH endogenous expression in human SH-SY5Y neuroblastoma cells by the antioxidant Trolox.Surface functionalisation of nanodiamonds for human neural stem cell adhesion and proliferation.Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture.Patient-specific pluripotent stem cells in neurological diseases.Stem cells as in vitro model of Parkinson's disease.Growing knowledge: using stem cells to study developmental neurotoxicity.Detailed expression analysis of regulatory genes in the early developing human neural tube.Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.Glucose-6-phosphatase-α participates in dopaminergic differentiation.Fasciculation and elongation protein zeta-1 (FEZ1) expression in reactive astrocytes in a rat model of Parkinson's disease.Intrastriatal Transplantation of Human Neural Stem Cells Restores the Impaired Subventricular Zone in Parkinsonian Mice.Effects of neural progenitor cell transplantation in children with severe cerebral palsy.Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
P2860
Q21134939-B48CD8BB-2D02-49D7-A6F7-F2480AD67B33Q27004330-179D1F71-E207-40B6-BF7A-B072F92029EBQ27322685-0D75BEA6-CA10-4C94-9872-5B64BC3ACD68Q28484677-8BD0618F-6225-489E-8762-109FE0C0FA06Q28550104-A590C118-878C-4F53-907A-4F0772F7DF3CQ28587554-2CFE4A64-FE54-450A-913E-3ED21D61A152Q30539060-5015A71B-829D-4990-962F-5DF71BD00AE2Q34939259-E7B48D41-0D82-467F-B6B7-505BB943AE3DQ35155196-144DE6AD-DC63-429F-9FA8-33B423E881E0Q35614156-FA69C279-A350-4A6E-824A-28E9B2DCE24AQ35619338-96116091-7B0C-4A34-9C55-B279BB2B652DQ36084830-5858DCB2-8E4F-47EC-B278-262035AF8C8CQ36164724-FA59D63F-0924-4866-A847-43678337EB17Q36324531-BAE0F33D-C922-4001-9EAA-8EF47EF5CA53Q36842220-407B2B8A-CCBE-4D15-ABAF-79BDCA573F9CQ37517917-D1508963-5451-4E48-8B3B-6E615AA6A02FQ37858416-9B02B004-A59E-4854-808B-505DD958E708Q37921767-E3F20F34-C9C9-4972-8141-8F4D14546069Q38066256-61593B8D-6C6A-4BA9-AA2A-31A383A8231DQ38203839-1C97FDD4-F2AC-49EA-BA45-4E55527399FBQ38223428-B23EBD3A-486E-46EB-9DD3-E1C97441B808Q38234170-301D65A4-FD86-4F5D-8301-7729449857BAQ38309820-6DD7EC93-C23F-4FF8-98EA-5D16725B6ABDQ38697315-83B6AB9E-935F-4A92-AE68-8025E094AF9FQ38715984-2DEBC5F6-61F0-4982-A5EA-439DE9972F80Q38921243-D8A763AC-800A-44AB-A579-61D00BC22568Q39377456-4B3287ED-D7D3-4C89-9550-8007B205151CQ39511432-AC27FC59-A8DC-48C7-B240-4A310434DE77Q41260891-7DA10AFB-1B11-4ED0-BEBE-AA8B67C31D48Q41812452-D7FF6A3B-3C99-41E0-9FFA-C66DFBA1880BQ41836711-C0926CEB-3916-42A2-967C-7B857B3EC3BAQ42159528-67B85220-523A-4854-936E-FAE29AF9F511Q42407798-8C263D8D-62EF-4A47-A6E8-77714DBF1797Q42780232-F4F22FF8-681C-4C05-80AC-344F357D06C2Q46056309-6882BCA0-C644-4B6A-84E6-3F78DBD5AF58Q47922279-183C82EC-BEB8-4E59-98A4-9534045ACC11Q47929850-860AB887-F1DA-4703-8004-9052047C950FQ48092963-091B9D5E-7DD2-4E4F-886C-7EB670F96DA2Q48555576-BCF5EFFF-F8C9-435D-A31C-D6B94ADA6E85Q48895003-B2D0C8D0-FCAF-4BD3-8770-563E969FA980
P2860
Towards stem cell replacement therapies for Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Towards stem cell replacement therapies for Parkinson's disease.
@en
Towards stem cell replacement therapies for Parkinson's disease.
@nl
type
label
Towards stem cell replacement therapies for Parkinson's disease.
@en
Towards stem cell replacement therapies for Parkinson's disease.
@nl
prefLabel
Towards stem cell replacement therapies for Parkinson's disease.
@en
Towards stem cell replacement therapies for Parkinson's disease.
@nl
P1476
Towards stem cell replacement therapies for Parkinson's disease.
@en
P304
P356
10.1016/J.BBRC.2010.04.037
P407
P577
2010-05-01T00:00:00Z